Table 1. Characteristics of patients with thyroid-associated ophthalmopathy (TAO) and subjects without TAO from whom the experimental orbital fibroblasts were obtained.
Patients with TAO | Subjects without TAO | |
---|---|---|
(n = 4) | (n = 4) | |
Mean age, years (range) | 46.5 (23–63) | 53.3 (31–69) |
Sex (m/f) | 2/2 | 1/3 |
Smoking (years) | 1 | 1 |
Graves’ dis | 0 | |
Radioactive iodine therapy | 1 | - |
Surgery | 0 | - |
Methimazole | 4 | - |
Treatment of TAO | 0/4 | |
Surgery | 4 | - |
Prednisolone | 3 | - |
Radiation | 1 | - |
Euthyroid | 4 | 4 |
TSH receptor antibodies | 4 | 0 |
CAS (range) | 3 (2–4) | (-) |
CAS: clinical activity score